🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07034417
Starting soon Not applicable

The Effectiveness Of BETY In Fibromyalgia

NCT07034417 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-07-12
Last updated
2025-06-24

Condition(s) studied

Fibromyalgia

Investigational drug(s) / intervention(s)

ExerciseHome exercise

Exercise: Cognitive Exercise Therapy Approach

Home exercise: Home exercise

Study summary

Fibromyalgia Syndrome (FMS) is a nonarticular, chronic rheumatic disorder of unknown etiology characterized by widespread musculoskeletal pain, impaired sleep quality, fatigue and the presence of identified tender points. Pain, the main symptom of the disease, is described as chronic and widespread. It is reported that the pain usually starts in the neck and shoulders but becomes widespread by being felt in various parts of the body during the day. Although it is difficult to localize the pain, it is reported to be localized to the paracervical and trapezius muscle and paralumbar and gluteal body parts.

Cognitive Exercise Therapy Approach is an innovative exercise approach developed on the basis of biopsychosocial model on individuals with rheumatism. This method has a unique scale that offers biopsychosocial assessment. There is the Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ). Validity, reliability and sensitivity studies of BETY-BQ have been conducted in individuals with fibromyalgia. This study aims to examine the effect of BETY, an exercise approach developed on the basis of the biopsychosocial model, on individuals with fibromyalgia.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Being diagnosed with fibromyalgia * 18 years of age or older * Being literate * Having read and signed the informed consent * Not exercising regularly in the last 3 months Exclusion Criteria: * Having a malignant disease * Pregnancy * Having chronic infectious or other rheumatologic diseases * Having undergone a surgical operation in the last 6 months * Collagen tissue disease * History of peripheral vascular disease or neuropathy * Presence of diseases that cannot be controlled and prevent exercise

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Alanya Alaaddin Keykubat University Antalya Alanya

More Aysima Barlak trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07034417 on ClinicalTrials.gov ↗ ← All trials in Turkey